SCHEMBL22978634

SCHEMBL22978634

[CH2]c1cc(OCC)n(C)n1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
NQO1 P15559 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10715626 0.78 KDM1A (0.37) ALDH1A1MAPTMEN1KMT2A
SCHEMBL24685885 0.76 ALDH1A1 (0.33) ALDH1A1MAPTMEN1KMT2ANQO1
SCHEMBL22978627 0.73 BCHE (0.30)
SCHEMBL24510005 0.73 KDM4E (0.33) ALDH1A1MAPTKMT2A
SCHEMBL21607865 0.73 NOTUM (0.37) ALDH1A1MEN1KMT2A
SCHEMBL21607979 0.72 LMNA (0.35) ALDH1A1
SCHEMBL4753817 0.72 ALDH1A1 (0.54) ALDH1A1KMT2A
SCHEMBL21597038 0.71 ATM (0.36) ALDH1A1
SCHEMBL23854653 0.71 MEN1 (0.33) ALDH1A1MEN1KMT2A
SCHEMBL21607903 0.68 KMT2A (0.48) ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026672-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS NOVARTIS AG (CH) 2021-02-18 WO disclosed